drugset / Trial / NCT06558461
Nebulised 3% Hypertonic Saline in Infants With Acute Bronchiolitis
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to determine the efficacy of nebulising 3% hypertonic saline in improving clinical symptoms and reducing the length of hospital stay in infants with acute bronchiolitis.
Timeline
- Start
- 2022-06-01
- Primary completion
- 2024-05-27
- Completion
- 2024-05-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sodium chloride | Unknown | 4 ml | Inhaled |